Zepp Health Corporation
ZEPP
$4.40
-$0.44-9.09%
NYSE
| 12/31/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -39.32% | -48.24% | -51.00% | -51.97% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -39.32% | -48.24% | -51.00% | -51.97% |
| Cost of Revenue | -- | -46.11% | -56.85% | -60.43% | -61.62% |
| Gross Profit | -- | -24.07% | -23.94% | -18.56% | -12.16% |
| SG&A Expenses | -- | 8.56% | 0.00% | -13.56% | -25.50% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -28.47% | -40.04% | -47.21% | -52.29% |
| Operating Income | -- | -105.23% | -55.01% | 8.36% | 55.39% |
| Income Before Tax | -- | -173.12% | -85.18% | 19.16% | 56.09% |
| Income Tax Expenses | -- | 992.71% | 663.46% | 152.07% | 128.10% |
| Earnings from Continuing Operations | -- | -213.04% | -143.72% | 0.91% | 38.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -38.75% | 13.25% | -67.65% | -46.02% |
| Net Income | -- | -213.73% | -144.00% | 0.73% | 38.54% |
| EBIT | -- | -105.23% | -55.01% | 8.36% | 55.39% |
| EBITDA | -- | -164.67% | -79.77% | 8.78% | 64.56% |
| EPS Basic | -- | -207.26% | -130.94% | 6.14% | 41.97% |
| Normalized Basic EPS | -- | -96.24% | -94.32% | 26.24% | 69.39% |
| EPS Diluted | -- | -192.40% | -122.46% | 3.57% | 39.23% |
| Normalized Diluted EPS | -- | -95.86% | -94.09% | 26.29% | 69.34% |
| Average Basic Shares Outstanding | -- | 4.52% | 6.39% | 4.41% | 2.65% |
| Average Diluted Shares Outstanding | -- | 3.17% | 4.99% | 3.04% | 3.98% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |